EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Long‐term opioid treatment and endocrine measures in chronic non‐cancer pain patients

Pernille D K Diasso iD, Dalia Abou-Kassem, Susanne D Nielsen, Katharina M Main, Per Sjøgren, Geana P Kurita

European Journal of Pain · 2023

DOI: 10.1002/ejp.2136 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Journal of Pain, 2023. Verfasst von Pernille D K Diasso und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark. Hauptthemen laut MEDLINE: Analgesics, Opioid, Chronic Pain. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 62 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Rigshospitalet.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The prevalence of chronic non‐cancer pain (CNCP) has increased dramatically the past decades, which combined with indiscriminate use of prescribed opioids has become a public health problem. Endocrine dysfunction may be a complication of long‐term opioid treatment (L‐TOT), but the evidence is limited. This study aimed at investigating the associations between L‐TOT and endocrine measures in CNCP patients.

Methods

Cortisol (spot and after stimulation), thyrotropin (TSH), thyroxin (T4), insulin‐like growth factor 1 (IGF‐1), prolactin (PRL), 17‐hydroxyprogesterone, androstenedione, dehydroepiandrosterone (DHEAS), sex hormone‐binding globulin (SHBG), total testosterone (TT) and free testosterone (fT) were measured. Group comparisons were done between CNCP patients in L‐TOT and controls as well as between patients on high‐ or low‐dose morphine equivalents.

Results

Eighty‐two CNCP patients (38 in L‐TOT and 44 controls not receiving opioids) were included. Low TT ( p = 0.004) and fT concentrations ( p < 0.001), high SHBG ( p = 0.042), low DEAS ( p = 0.017) and low IGF‐1 ( p = 0.003) in men were found when comparing those in L‐TOT to controls and high PRL ( p = 0.018), low IGF‐1 standard deviation score (SDS) ( p = 0.006) along with a lesser, but normal cortisol response to stimulation ( p = 0.016; p = 0.012) were found when comparing L‐TOT to controls. Finally, a correlation between low IGF‐1 levels and high opioid dose was observed ( p < 0.001).

Conclusions

Our study not only supports previous findings but even more interestingly disclosed new associations. We recommend future studies to investigate endocrine effects of opioids in larger, longitudinal studies. In the meanwhile, we recommend monitoring endocrine function in CNCP patients when prescribing L‐TOT. Significance This clinical study found associations between L‐TOT, androgens, growth hormone and prolactin in patients with CNCP compared to controls. The results support previous studies as well as add new knowledge to the field, including an association between high opioid dose and low growth hormone levels. Compared to existing research this study has strict inclusion/exclusion criteria, a fixed time period for blood sample collection, and adjustments for potential confounders, which has not been done before.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Analgesics, OpioidChronic PainMaleHumansInsulin-Like Growth Factor IHydrocortisoneProlactinTestosteroneGrowth Hormone

Substanzen

Analgesics, OpioidInsulin-Like Growth Factor IHydrocortisoneProlactinTestosteroneGrowth Hormone

Autor:innen und Institutionen

  • Department of Oncology, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
  • Multidisciplinary Pain Centre, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Infectious Diseases, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Growth and Reproduction and EDMaRC, Rigshospitalet-Copenhagen University Hospital, Copenhagen, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

ORCID-Profile: Pernille D K Diasso

Förderung

  • Rigshospitalet

Zitieren

APA

Diasso, P. D. K., Abou-Kassem, D., Nielsen, S. D., Main, K. M., Sjøgren, P., & Kurita, G. P. (2023). Long‐term opioid treatment and endocrine measures in chronic non‐cancer pain patients. European Journal of Pain. https://doi.org/10.1002/ejp.2136

Vancouver

Diasso PDK, Abou-Kassem D, Nielsen SD, Main KM, Sjøgren P, Kurita GP. Long‐term opioid treatment and endocrine measures in chronic non‐cancer pain patients. European Journal of Pain. 2023. doi:10.1002/ejp.2136

BibTeX
@article{Diasso2023,
  author = {Diasso, Pernille D K and Abou-Kassem, Dalia and Nielsen, Susanne D and Main, Katharina M and Sjøgren, Per and Kurita, Geana P},
  title = {Long‐term opioid treatment and endocrine measures in chronic non‐cancer pain patients},
  journal = {European Journal of Pain},
  year = {2023},
  doi = {10.1002/ejp.2136}
}
Kostenlos starten →